LVTX(Delisted)
LAVA Therapeutics·NASDAQ
--
--(--)
4.73 / 10
Netural
Fundamentals score 4.7/10 with strong PB/PB-ROE (Group 1, 16.99% returns) but weak Revenue-MV/Asset-MV (Group 2/3). Negative ROE (-1.52) offsets positive Profit-MV/Cash-MV, leading to neutral appraisal.
Analysis Checks(7/10)
Revenue-MV
Value-0.18
Score1/3
Weight7.75%
1M Return8.00%
Value-0.18
Score1/3
Weight7.75%
1M Return8.00%
PCF
Value-1.36
Score1/3
Weight6.39%
1M Return7.64%
Value-1.36
Score1/3
Weight6.39%
1M Return7.64%
Profit-MV
Value0.43
Score2/3
Weight9.17%
1M Return9.79%
Value0.43
Score2/3
Weight9.17%
1M Return9.79%
ROE
Value-1.52
Score2/3
Weight11.36%
1M Return11.61%
Value-1.52
Score2/3
Weight11.36%
1M Return11.61%
Asset-MV
Value-0.44
Score1/3
Weight12.06%
1M Return11.72%
Value-0.44
Score1/3
Weight12.06%
1M Return11.72%
PB
Value0.79
Score3/3
Weight17.87%
1M Return16.99%
Value0.79
Score3/3
Weight17.87%
1M Return16.99%
GPM
Value0.46
Score2/3
Weight7.83%
1M Return8.45%
Value0.46
Score2/3
Weight7.83%
1M Return8.45%
PB-ROE
Value-0.26
Score3/3
Weight17.01%
1M Return16.72%
Value-0.26
Score3/3
Weight17.01%
1M Return16.72%
Fixed assets turnover ratio
Value9506.61
Score3/3
Weight1.19%
1M Return1.68%
Value9506.61
Score3/3
Weight1.19%
1M Return1.68%
Cash-MV
Value0.45
Score2/3
Weight9.37%
1M Return9.86%
Value0.45
Score2/3
Weight9.37%
1M Return9.86%
Revenue-MV
Value-0.18
Score1/3
Weight7.75%
1M Return8.00%
Value-0.18
Score1/3
Weight7.75%
1M Return8.00%
PB
Value0.79
Score3/3
Weight17.87%
1M Return16.99%
Value0.79
Score3/3
Weight17.87%
1M Return16.99%
PCF
Value-1.36
Score1/3
Weight6.39%
1M Return7.64%
Value-1.36
Score1/3
Weight6.39%
1M Return7.64%
GPM
Value0.46
Score2/3
Weight7.83%
1M Return8.45%
Value0.46
Score2/3
Weight7.83%
1M Return8.45%
Profit-MV
Value0.43
Score2/3
Weight9.17%
1M Return9.79%
Value0.43
Score2/3
Weight9.17%
1M Return9.79%
PB-ROE
Value-0.26
Score3/3
Weight17.01%
1M Return16.72%
Value-0.26
Score3/3
Weight17.01%
1M Return16.72%
ROE
Value-1.52
Score2/3
Weight11.36%
1M Return11.61%
Value-1.52
Score2/3
Weight11.36%
1M Return11.61%
Fixed assets turnover ratio
Value9506.61
Score3/3
Weight1.19%
1M Return1.68%
Value9506.61
Score3/3
Weight1.19%
1M Return1.68%
Asset-MV
Value-0.44
Score1/3
Weight12.06%
1M Return11.72%
Value-0.44
Score1/3
Weight12.06%
1M Return11.72%
Cash-MV
Value0.45
Score2/3
Weight9.37%
1M Return9.86%
Value0.45
Score2/3
Weight9.37%
1M Return9.86%
Is LVTX undervalued or overvalued?
- LVTX scores 4.73/10 on fundamentals and holds a Fair valuation at present. Backed by its -95.51% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 13.86% earnings growth, these metrics solidify its Netural investment rating.
